Metraipolis › archive › dc_9e9cd660dc6b

How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases — Europe PMC PMID:41361762

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41361762
DOI
10.1186/s13023-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-07T17:57:16.651Z
SHA-256 of the archived text
ec4e08438c5a0eab4f5c2b8ef3a14454d865c12fd405fa6f6b07319843283b2f
Stable URL of this page
https://metraipolis.com/documento/dc_9e9cd660dc6b

How to cite

How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases — Europe PMC PMID:41361762 — Europe PMC (en), https://europepmc.org/article/MED/41361762 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9e9cd660dc6b (Metraipolis archive dc_9e9cd660dc6b, sha256 ec4e08438c5a0eab4f5c2b8ef3a14454d865c12fd405fa6f6b07319843283b2f)
BibTeX
@misc{dc9e9cd660dc6b,
  title = {How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases — Europe PMC PMID:41361762},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41361762},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9e9cd660dc6b; sha256 ec4e08438c5a0eab4f5c2b8ef3a14454d865c12fd405fa6f6b07319843283b2f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41361762. Agents can read the archived copy with the MCP tool read_document.